Lilly’s Alimta fails to extend survival in lung cancer study
Eli Lilly and Co. said Thursday that its cancer drug Alimta didn’t extend overall survival when combined with Roche Holding AG’s Avastin in patients with a form of lung tumor.
Health Care & Life Sciences
Articles
St. Vincent adds Bloomington hospital to its fold
Indianapolis-based St. Vincent Health will manage operations at Monroe Hospital in Bloomington under an agreement announced on Tuesday. Monroe gives St. Vincent a line of hospitals stretching from Indianapolis to Bedford and even farther south to Salem and Evansville.
Bounty on Braly? $1.4 billion
Investors who called strongly for the head of WellPoint Inc. CEO Angela Braly got what they wanted last week. In response, they bid up WellPoint's share price by $1.4 billion on the day after she resigned.
Two more clinical trials go against Lilly
In the midst of Eli Lilly and Co.’s surprisingly positive news about its experimental Alzheimer’s drug, the company suffered two other setbacks with former stars of its pipeline.
IU study: Health majors have best shot at jobs
An Indiana University study has found that what people studied in college had a direct effect on their chances of employment during the Great Recession.
Eli Lilly’s top lawyer to retire at end of year
Indianapolis-based drugmaker Eli Lilly and Co. said Thursday its general counsel, Robert Armitage, will retire at the end of the year and be replaced by deputy general counsel Michael Harrington.
Drug company makes $181M settlement with states
Janssen Pharmaceuticals Inc. and parent company Johnson & Johnson on Thursday announced a $181 million settlement with 36 states, including Indiana, and the District of Columbia over charges of marketing anti-psychotic drugs for non-approved uses.
Lilly stops testing of experimental schizophrenia drug
Eli Lilly and Co. halted testing on an experimental treatment for schizophrenia after the company determined the drug was unlikely to show a benefit in patients.
Departing CEO Braly due to get $15M exit package
WellPoint Inc. is expected to give about $15 million in cash, stock and benefits to former CEO Angela Braly on her way out the door, based on the terms of a separation agreement filed by the company Wednesday morning. And the payout could be even more lucrative based on the company’s future stock price.
WellPoint launches search for new CEO after Braly resignation
Investors are looking for a CEO who can right the Indianapolis-based company’s financial performance and integrate WellPoint’s recent deals to buy Medicaid insurer Amerigroup Corp. and vision company 1-800-Contacts Inc.
Salmonella at Indiana farm matches outbreak strain
A southwestern Indiana cantaloupe farm is the source of at least some of the salmonella responsible for an outbreak that sickened people in 21 states and killed two Kentucky residents, the Food and Drug Administration said Tuesday.
Braly’s departure occurred sooner than many expected
Even though CEO Angela Braly was facing withering criticism, analysts thought WellPoint would be reluctant to change CEOs while its $4.9 billion acquisition of Amerigroup Corp. was pending.
Records for 55,000 patients stolen from oncology group
The Cancer Care Group in Indianapolis said a laptop computer bag containing private information on as many as 55,000 patients has been stolen.
Candidate Gregg ‘leaning’ to hybrid health exchange
Democratic gubernatorial candidate John Gregg says he likely would support a hybrid health insurance exchange for Hoosiers if elected in November.
Does Lilly have enough on Alzheimer’s drug?
After Eli Lilly and Co. found a “glimmer of hope” in its test of its experimental Alzheimer’s drug, doctors and stock analysts generally concluded the company needs to conduct another long clinical trial to prove the drug’s effect. But one stock analyst thinks Lilly already has what it needs to ask for approval for its drug.
Subsidies might hang in the balance of state’s exchange decision
There’s more than political philosophy at stake as Indiana’s candidates for governor wrestle over whether the state should start its own health insurance exchange. There’s potentially a lot of money for low- and moderate-income Hoosiers at stake, too.
Lilly’s Alzheimer’s finding triggers investor hope, doctor caution
While investors supported the sliver of promise offered when Eli Lilly and Co. said its Alzheimer’s drug may slow progression early in the disease, doctors weren’t as impressed, saying it could take years to find out for sure.
Boneham supports hybrid health exchange for state
The Libertarian candidate for governor said he initially favored a state-run exchange to administer the federal health care law, but chose a joint venture with the federal government after meeting with the governor's staff.
Lilly wins appeal upholding patent for Alimta cancer drug
Eli Lilly and Co. won a U.S. appeals court ruling that upholds the validity of a patent for the lung-cancer drug Alimta and blocks generic competition through 2017. Alimta generated $2.5 billion in sales last year.
$100M IU neuroscience center set to open
A $100 million neuroscience center Indiana University officials say will offer a "one stop shop" for patients recovering from head and spinal injuries, strokes and other medical conditions is days away from opening its doors in Indianapolis.